Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 18, 2003

View Archived Issues

Company Profile: Sirus Pharmaceuticals

Local analgesic effects described for tricyclic antidepressants in rats

Aripiprazole is safe and effective in the treatment of schizophrenia and schizoaffective disorders

Hemispherx enters research agreement with Johann Wolfgang Goethe U. Hospital

Alzheimer's vaccine goal of new collaboration

AIDS Healthcare Foundation to urge FDA to withdraw Trizivir approval

OvuLook saliva-based ovulation system launched

Generex completes Antigen Express acquisition

Transkaryotic Therapies retakes Factor VIII gene therapy rights from Wyeth

Santen seeks Japanese manufacturing approval for vernal keratoconjunctivitis treatment

Elite authorizes merger negotiations with Nostrum

Titan updates key program status

New, potent inhibitors of rat 17alpha-hydroxylase/C17,20-lyase

Potent and selective non-imidazole human histamine H4 receptor antagonists

Affimed and Dyax enter crosslicensing agreement for phage display technologies

Merck KGaA acquires ProteoPlex

Novel nAchR ligands under study at Sanofi-Synthelabo

Acadia patent covers new muscarinic agonists with utility in cognition disorders

Novel 5-HT2A receptor inverse agonists evaluated by Acadia scientists

New beta-secretase inhibitors identified by Elan and Pharmacia team

Novel 5-HT2C receptor ligands and their use in depression and anxiety

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...